The aim was to investigate whether preoperative weight loss results in improved clinical outcomes in surgical patients with clinically significant obesity.
Introduction
Globally, obesity has more than doubled since 1980. In 2016, more than 1⋅9 billion adults were overweight and over 600 million were obese 1 . As a consequence, overweight and obese patients are increasingly being referred for surgical treatments 2 . This presents challenges to healthcare workers as operations may be technically more difficult in obese patients, perioperative care may be more complex, and the presence of obesity-associated co-morbidities, such as diabetes, hypertension or obstructive sleep apnoea, increases the risks of postoperative complications and infections 3, 4 .
It is common for treatment to be deferred in obese and overweight patients until they have lost weight, typically following dietary modification with or without exercise 3 . In some countries, overweight and obese patients have restrictions to routine surgery unless they have undergone a successful weight loss programme 2, 5, 6 . In contrast, observational analyses 7 -9 suggest that overweight and obese patients may have improved outcomes after surgery compared with normal-weight or underweight patients. To address this apparent contradiction, a systematic review was undertaken to evaluate the evidence supporting preoperative bodyweight reduction through lifestyle changes in obese subjects undergoing any type of surgery. Previous systematic reviews were identified as part of this search, but these either assessed only the correlation between preoperative and postoperative weight loss, without review of other clinical outcomes 10 , were limited to bariatric surgery only 11 , or restricted to a very low-calorie diet 12 . The authors hypothesized that, if beneficial, preoperative weight loss programmes would result in improved clinical outcomes.
Methods
This systematic review and aggregate data meta-analysis was performed using the methods described in the Cochrane Handbook for Systematic Reviews of Interventions 13 and reported according to PRISMA guidelines 14 . The review protocol was registered in the PROSPERO international prospective register of systematic reviews (CRD 42017059109) on 12 March 2017 and updated in February 2018. The MOOSE reporting guidelines were used 15 . The patients or public were not involved in the design or conduct of this study.
Study eligibility
RCTs, controlled before-and-after studies, cohort studies, cross-sectional studies and case-control studies were included.
Data sources
Potentially eligible manuscripts were identified by searching PubMed, MEDLINE, Embase and CINAHL Plus databases, and grey literature using a combination of subject headings and text words to identify relevant publications from inception to February 2018. The grey literature included but was not restricted to: conference papers, ongoing clinical trials, academic papers, theses, facts sheets, bulletins, research and committee reports, and government reports. The AACODS (Authority, Accuracy, Coverage, Objectivity, Date and Significance) assessment was used to evaluate grey literature materials 16 . The search terms are available in Appendix S1 (supporting information). The keyword search engine used was the National Institute for Health and Care Excellence (NICE) Healthcare Databases Advanced Search Engine (https://hdas.nice.org.uk/). All the responsible searchers were medically qualified. Additionally, the reference lists of eligible trials and reviews were examined for eligibility based on the review inclusion criteria. Searches were not restricted by language or publication status. Translation of non-English studies was performed using certified translators if necessary.
Study selection
Three reviewers screened the results of the literature search independently of each other and identified studies that met the inclusion criteria. The selected studies were stored and processed using EndNote X7 software (Clarivate Analytics, Philadelphia, Pennsylvania, USA). Full texts of these studies were retrieved and further assessed for inclusion, with agreement between the three reviewers. Excluded studies and the reason for exclusion were recorded. Disagreements were resolved by discussion and consensus. In instances where this was not possible, the senior author determined whether or not the study was included.
Data extraction
Using a standard form, three reviewers extracted the following data from the included studies: year and language of publication; country; study type, setting and population; sample size; participant demographics and baseline characteristics; type of surgery; type of weight loss intervention; and outcomes assessed.
Participants were all patients subjected to behavioural lifestyle changing weight loss interventions and undergoing any type of surgery. No age restrictions were applied (Table S1, supporting information). Interventions were dietary interventions (with or without exercise) to achieve weight loss before surgery. Studies evaluating pharmacological weight loss therapies such as glucagon-like peptide 1 agonists were excluded. Controls comprised patients not receiving dietary interventions (with or without exercise), or alternative goal-directed therapy groups.
The primary outcome was 30-day mortality or all-cause in-hospital mortality. Postoperative secondary outcomes at any time point included: intervention-related weight loss; perioperative bleeding (defined as clinical, laboratory and/or imaging evidence of bleeding); duration of operation; duration of hospital stay (days from date of intervention to date of discharge); myocardial infarction; pulmonary embolism; infections; correction of co-morbidities; need for reoperation; and overall complication rate.
Risk-of-bias assessment
Risk of bias was evaluated by two authors using the Cochrane risk-of-bias tool for RCTs 13 and the Newcastle-Ottawa Scale for cohort and case-control studies 17 . The assessment of bias evaluated the selected studies for any of the following: random sequence generation; allocation concealment; blinding of participants, healthcare providers or outcome assessors; incomplete outcome data; attrition; and other sources of bias including funding source.
Where ten (based on the number of studies selected for quantitative analysis) or more studies were identified for each outcome, two authors assessed publication bias by visual assessment of funnel plots and Egger's intercept test 13 .
Data synthesis
Meta-analyses were performed using the software package Review Manager version 5.3 13 . Random-effects models were used to calculate pooled effect estimates for dichotomous data 18 . For continuous outcomes, pooled mean differences (MDs) were calculated using the inverse-variance method.
Measures of treatment effect
The odds ratio (OR) was calculated for dichotomous variables, and MD for continuous variables, each with 95 per cent confidence intervals.
Dealing with missing data
When possible, the analysis was limited to studies that reported results according to intention to treat rather than per protocol. For dichotomous data presented only as percentages, the frequencies were estimated from reported sample sizes for this outcome. For continuous outcomes, if the mean and the standard deviation were not available from the trial report, this information was sought from the trial authors, or calculated from median (i.q.r.) values using the software available in Review Manager version 5.3 19 .
Assessment of heterogeneity
The heterogeneity within each meta-analysis was explored using the Cochran's Q test and expressed as the percentage of heterogeneity due to variation rather than to chance (I 2 value) 20 . An I 2 value of 0-40 per cent indicated no heterogeneity or mild inconsistency, 40-80 per cent indicated moderate inconsistency, and over 80 per cent indicated severe inconsistency. P < 0⋅100 was considered statistically significant.
Subgroup analyses
Post hoc moderator analyses explored interactions for variance between studies based on: type of study (RCT versus non-RCT), type of surgery (laparoscopic versus open) and intervention type (diet versus diet and exercise). The results were expressed as MD for continuous variables and OR with non-overlapping 95 per cent confidence interval for dichotomous variables. Two-tailed P < 0⋅050 was considered statistically significant 13 . No meta-regression was performed owing to the limited number of studies included.
Results

Description of studies
A total of 11 841 references were retrieved through electronic searches of PubMed (3675), MEDLINE (3774), Embase (3526) and CINAHL Plus (866). After the exclusion of 11 619 duplicates and irrelevant articles according to title and abstracts, 222 full-text articles remained for further evaluation (Fig. 1) . The majority of the excluded studies were conducted in non-surgical patients (117), studied only postoperative weight loss as a result of bariatric surgery (38) , used a pharmacological agent for weight loss (31) or were non-interventional studies (no intervention identified) (15) . Among these, a prospective study 21 was identified that analysed preoperative weight loss as a predictor of weight reduction after 3-4 years and was excluded. Also excluded was a randomized trial 22 in which a dietary weight loss intervention was applied in both groups. A third study 23 evaluated the relationship between the number of preoperative weight loss attempts or maximum preoperative weight loss using conventional methods and the individual's successful postoperative weight loss. One article 24 was excluded as it presented follow-up data from a previously excluded study and another 25 that presented only preliminary data. Of the remaining studies, 21 met the inclusion criteria. Following detailed assessment of the full manuscripts, five studies (2 reviews 11,12 , 2 with no control groups 26,27 and 1 with no relevant reported outcomes 28 ) were excluded. The remaining 16 publications included four RCTs 29 -32 and 12 cohort studies 33 -44 , of which four [33] [34] [35] 37 were prospective and eight 36,38 -44 retrospective. No additional references were identified by reference searching, leaving 16 articles that met the inclusion criteria and provided quantitative data for inclusion in the analysis (Fig. 1) .
Participants
The quantitative analysis included 6060 participants (3552 treated and 2508 controls) in these 16 studies published between 1995 and 2016. All but one 42 of the studies considered patients undergoing bariatric surgery. The enrolled patients underwent the following types of surgery: laparoscopic Roux-en-Y gastric bypass, five studies (2 RCTs 29,31 and 3 cohort studies 36, 38, 40 ); open or laparoscopic Roux-en-Y gastric bypass, three studies 33, 34, 41 ; open Roux-en-Y gastric bypass, four studies 35, 37, 39, 44 ;
Records identified through database searches n = 11 841
Embase n = 3526 MEDLINE n = 3774 CINAHL n = 866 PubMed n = 3675
Articles reviewed for more detailed evaluation (including cross-references) n = 222
Records excluded after title review (duplicates, irrelevant articles, inappropriate patient groups or outcomes) n = 11 619
Records excluded after abstract review n = 201 Non-surgical patients n = 117 Weight loss only due to surgery n = 38 Pharmacological weight loss n = 31 Non-interventional studies n = 15
Full-text articles excluded n = 5 No control group n = 2 Review articles n = 2 No relevant outcomes reported n = 1 mixed types of gastric banding procedure (vertical banded gastroplasty or laparoscopic adjustable gastric bands), two studies 30, 43 ; biliopancreatic diversion, one study 32 ; and total knee or hip replacement, one cohort study 42 . The mean age of participants in these trials ranged from 39 to 50 years, and the mean follow-up time was 6-51 months ( 
Assessment of bias
None of the RCTs was classified as having a low risk of bias (Fig. S1, supporting information) . There was a high risk of allocation and selection bias in one trial 31 . Five studies 32, 35, 40, 41, 43 were at high risk of performance bias, detection bias and incomplete outcome data. Quality assessment for observational studies identified none as being of high quality, defined as scoring maximum points in all three domains of the Newcastle-Ottawa Scale (Table  S3 , supporting information).
Effects of weight loss intervention
The summary effect estimates, and details for all primary and secondary outcomes are described in Figs 2 and 3 , and Fig. S2 and Table S4 (supporting information).
Primary outcome
The primary outcome, either all-cause in-hospital mortality 29, 31, 33, 36, 37, 39, 40 or mortality related to the operation occurring within 30 days 34, 35 , was reported in nine studies (2 RCTs and 7 cohort studies). Random-effects meta-analysis did not show a statistically significant difference in mortality between the intervention and control groups (OR 1⋅41, 95 per cent c.i. 0⋅24 to 8⋅40; P = 0⋅71), with no inconsistency (I 2 = 0 per cent, P = 0⋅66) (Fig. 2) .
Alami et al. 31 Harnisch et al. 40 Huerta et al. 39 Huerta et al. 35 Jamal et al. 34 Martin et al. 37 Riess et al. 36 Still et al. 33 Van Nieuwenhove et al. 29 0 Total Total events Heterogeneity: τ 2 = 0·00; χ 2 = 0·83, 2 d.f., P = 0·66; I 2 = 0% Test for overall effect: Z = 0·38, P = 0·71 
Secondary outcomes
Preoperative weight loss was reported in 13 of the 16 studies, which included 1572 participants from three RCTs 29 -31 and ten cohort studies [32] [33] [34] [36] [37] [38] [39] [40] [41] 43 . The pooled effect estimate suggested that the interventions resulted in significant weight reduction relative to that in controls: MD -7⋅42 (95 per cent c.i. -10⋅09 to -4⋅74) kg (P < 0⋅001). However, there was severe inconsistency for this outcome (I 2 = 97 per cent, P < 0⋅001) (Fig. S2 , supporting information). Duration of operation was available in six studies with 1025 participants (2 RCTs 29,31 and 4 cohort studies 36,38 -40 ) . Although operating time was shorter in the intervention groups, this finding was not statistically significant: MD -11⋅58 (-26⋅41 to 3⋅26) min (P = 0⋅13). There was severe inconsistency for this outcome (I 2 = 95 per cent, P < 0⋅001).
Duration of hospital stay was reported in six studies with 1515 participants (1 RCT 31 and 5 cohort studies 33, 35, 36, 38, 39 ). The pooled effect estimate suggested that length of stay was shorter in the intervention groups (mean 3⋅2 versus 4⋅4 days): MD -1⋅26 (-2⋅10 to -0⋅41) days (P = 0⋅003). There was severe inconsistency for this outcome (I 2 = 97 per cent, P < 0⋅001).
Perioperative bleeding was documented in five studies with 1011 participants (2 RCTs 29,31 and 3 cohort studies 36, 40, 41 ). The use of a preoperative weight loss intervention did not result in a reduction in perioperative bleeding (OR 1⋅00, 95 per cent c.i. 0⋅44 to 2⋅31; P = 0⋅99), with mild inconsistency (I 2 = 3 per cent, P = 0⋅39).
Myocardial infarction was reported in five studies with 930 participants (2 RCTs 29,31 and 3 cohort studies 36, 39, 40 ).
The preoperative weight loss intervention did not result in significant reductions in myocardial infarction rates (OR 0⋅43, 0⋅02 to 11⋅09; P = 0⋅61). The level of inconsistency could not be calculated as only one patient with myocardial infarction was reported.
Data on pulmonary embolism were available in six studies with 1254 participants (2 RCTs 29,31 and 4 cohort studies 34, 36, 39, 40 ). The preoperative weight loss intervention did not result in significant decreases in perioperative pulmonary embolism (OR 1⋅54, 0⋅31 to 7⋅58; P = 0⋅60), with no inconsistency (I 2 = 0 per cent, P = 0⋅63).
Infection rates were reported in nine studies with 4669 participants (2 RCTs 29,31 and 7 cohort studies 34, [36] [37] [38] [40] [41] [42] ). The preoperative weight loss intervention did not reduce postoperative infection rates (OR 0⋅79, 0⋅53 to 1⋅18; P = 0⋅25), with no inconsistency (I 2 = 0 per cent, P = 0⋅89).
Correction of co-morbidities was addressed in two cohort studies 34, 40 with 527 participants. Preoperative weight loss intervention did not lead to a significant correction of co-morbidities (OR 1⋅04, 0⋅61 to 1⋅78; P = 0⋅89), with no inconsistency (I 2 = 0 per cent, P = 0⋅85). Reoperation rates were reported in three studies with 617 participants (1 RCT 31 and 2 cohort studies 36, 40 ). The preoperative weight loss intervention did not significantly decrease overall reoperation rates (OR 1⋅21, 0⋅33 to 4⋅42; P = 0⋅78), with no inconsistency (I 2 = 0 per cent, P = 0⋅51).
Ten studies with 1652 participants reported overall complications (2 RCTs 29,31 and 8 cohort studies 34 -41 ) . The preoperative weight loss intervention reduced overall rates of perioperative complications, but this was not statistically Alami et al. 31 Harnisch et al. 40 Huerta et al. 39 Burguera et al. 32 Fujioka et al. 41 Kalarchian et al. 30 Liu et al. 38 Parikh et al. 43 Jamal et al. 34 Martin et al. 37 Riess et al. 36 Still et al. 33 Van Nieuwenhove et al. 29 -8·2(3·65) Test for overall effect: Z = 5·43, P < 0·001 significant (OR 0⋅80, 0⋅55 to 1⋅17; P = 0⋅26), with mild inconsistency (I 2 = 27 per cent, P = 0⋅19).
Publication bias
As only three studies reported that deaths had occurred (Fig. S3 , supporting information), Egger's test was not performed.
Subgroup analyses
Subgroup analyses demonstrated significant interactions between study type (RCTs versus observational studies) and operation type (open versus laparoscopic) with the effect estimates for mean preoperative weight loss (Table S5 , supporting information). The mean difference in weight loss reported in observational analyses was greater than that reported for RCTs: MD 15⋅50 (95 per cent c.i. 12⋅52 to 18⋅48) versus -7⋅58 (-8⋅60 to -6⋅54) kg respectively. The mean difference in weight loss was also greater in studies of open bariatric surgery compared with those of laparoscopic surgery: MD 15⋅50 (12⋅52 to 18⋅48) versus 4⋅50 (3⋅69 to 5⋅31) kg respectively (I 2 = 98 per cent, P < 0⋅001). There was also an interaction between operation type and duration of hospital stay. The MD in studies of open bariatric surgery was -0⋅70 (-0⋅83 to -0⋅57) days and that for laparoscopic procedures was -0⋅07 (-0⋅25 to 0⋅11) days (I 2 = 95 per cent, P < 0⋅001).
Sensitivity analyses
No sensitivity analysis stratified by methodological quality was performed as no study was considered to be at low risk of bias.
Discussion
Subgroup analyses indicated that the inconsistency between studies for the duration of hospital stay may have been attributable to differences in operation type (open versus laparoscopic). A previous systematic review 10 addressed the effect of preoperative weight loss on sustained weight loss after bariatric surgery, but did not assess any other clinical outcomes and showed inconsistencies. Other reviews were either limited to bariatric surgery only 11 , or restricted to a very low-calorie diet 12 .
The inconsistency in the non-randomized studies may reflect the presence of selection or confounding bias in these studies (such as co-morbidities, clinical setting or different weight loss targets as intervention). Another limitation of the review is the lack of access to patient-level data; consistent analyses of all studies can be done only when data on individual patients are combined. All 16 studies were limited in terms of design and methodological quality. The three RCTs had risks of procedural, detection, attrition and reporting bias. The protocol compliance was not reported, and trial protocols were not published or registered. The observational studies had methodological limitations including comparisons with unmatched controls and attrition bias. The reporting of outcomes was also heterogeneous between studies, thereby limiting the number of studies that could be included in the analysis of each outcome.
The subgroup analyses demonstrated that observational studies reported smaller benefits in terms of shorter operating times than RCTs. This inconsistency can be attributed to the type of surgery performed. The study 42 with patients undergoing hip and knee replacements was excluded from the subgroup analysis to avoid skewed data, based on the study having sepsis as its only outcome relevant to this review. Several studies 31, 35, 38, 39 that have evaluated laparoscopic bariatric surgery also demonstrated reductions in operating time and hospital stay compared with those of open bariatric surgery. It may be speculated that the technical challenges faced by the surgeon are attenuated by reductions in liver size that accompany low-energy diets to a greater degree in laparoscopic than open surgery 29 . The numbers of studies and patients in each subgroup analysis was small and these subgroup analyses were conducted post hoc. These findings should be therefore be considered hypothesis-generating only. Finally, only short-term clinical effects of preoperative weight loss were evaluated in the studies identified by the searches. The possibility that preoperative weight loss programmes may have longer-term clinical benefits cannot be excluded.
Patients undergoing bariatric surgery are severely obese and have metabolic syndrome, including type 2 diabetes in many instances. Short-term lifestyle weight loss interventions have limited efficacy in these conditions owing to the hormonal and metabolic changes that favour weight gain 45 -47 . Obese and overweight patients are often considered at increased risk of postoperative complications. As a consequence, it is common practice to defer surgery until significant weight loss has been achieved. Indeed, it is mandated that obese patients must demonstrate evidence of weight loss (10 per cent) 2,5 before being considered eligible for surgical treatments. The present data suggest that weight loss may be achievable without surgery, but that the modest advantages achieved with weight loss of less than 10 kg may not be enough to reduce perioperative risks in patients with clinically significant obesity.
